Adderall and Mydayis are trade names for a combination drug called mixed amphetamine salts containing four salts of amphetamine. The mixture is composed of equal parts racemic amphetamine and dextroamphetamine, which produces a ratio between dextroamphetamine and levoamphetamine, the two enantiomers of amphetamine.
Stimulant Narcolepsy Agents
Alcoholism, substance abuse
Amphetamine; dextroamphetamine is contraindicated in patients with a history of substance abuse. Evaluate the child or adult patient for a history (or a family history) of abuse of prescription medicines or street drugs, or abuse or dependence on alcohol (alcoholism). Amphetamine; dextroamphetamine combinations have a high potential for abuse. Administration of amphetamines for a prolonged period of time may lead to physical and psychological drug dependence. Misuse of amphetamines may cause sudden death and serious cardiovascular adverse events. The least amount reasonable should be prescribed or dispensed at one time in order to limit the potential for overuse or drug diversion. Symptoms of chronic intoxication include insomnia, irritability, change in personality, and psychotic symptoms that may be clinically indistinguishable from psychotic disorders.
Rx, schedule II
Central nervous system (CNS) stimulant
Used for attention-deficit hyperactivity disorder (ADHD) and narcolepsy
Patients with structural heart defects, cardiomyopathy, or heart-rhythm disturbances may be at risk for adverse cardiac events
COMMON BRAND NAMES
Adderall, Adderall XR, Mydayis
Adderall XR/Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate/Amphetamine, Dextroamphetamine/Mydayis Oral Cap ER: 5mg, 10mg, 15mg, 20mg, 25mg, 30mg
Adderall/Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate/Amphetamine, Dextroamphetamine Oral Tab: 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg, 30mg